Works matching DE "NATCO Pharma Ltd."
Results: 12
India's IP snub.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 4, p. 362, doi. 10.1038/nbt0408-362b
- By:
- Publication type:
- Article
Court sides with generics company over Tamiflu patent.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 6, p. 408, doi. 10.1038/nrd4352
- Publication type:
- Article
Natco licensed to undercut Bayer drug price.
- Published in:
- TCE: The Chemical Engineer, 2012, n. 850, p. 16
- Publication type:
- Article
Neural Networks Application in Predicting Stock Price of Pharma Companies : A Case Study of NATCO Pharma.
- Published in:
- Finance India, 2017, v. 31, n. 1, p. 155
- By:
- Publication type:
- Article
Recent Developments in Compulsory Licensing of Pharmaceutical Patents in India.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 2, p. 64, doi. 10.5912/jcb733
- By:
- Publication type:
- Article
Regulatory Writing.
- Published in:
- Medical Writing, 2012, v. 21, n. 2, p. 173, doi. 10.1179/2047480612Z.00000000038
- By:
- Publication type:
- Article
IPR NEWS.
- Published in:
- Journal of Intellectual Property Rights, 2012, v. 17, n. 3, p. 256
- Publication type:
- Article
Bayer case may set cost precedent.
- Published in:
- Journal of Intellectual Property Rights, 2012, v. 17, n. 2, p. 171
- Publication type:
- Article
Natco Pharma seeks compulsory iicence for copy of Pfizer drug.
- Published in:
- Journal of Intellectual Property Rights, 2011, v. 16, n. 1, p. 53
- Publication type:
- Article
A licence to lower costs.
- Published in:
- Chemistry & Industry, 2012, v. 76, n. 10, p. 45, doi. 10.1002/cind.7610_15.x
- Publication type:
- Article
Patent battle decisive.
- Published in:
- 2012
- Publication type:
- Opinion
India's patent laws — on trial.
- Published in:
- Chemistry & Industry, 2011, n. 17, p. 5
- By:
- Publication type:
- Article